A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
Antimicrobial agents and chemotherapy, 2020-08, Vol.64 (9) [Peer Reviewed Journal]Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.01061-20 ;PMID: 32661006
Full text available